Squarepoint
RPTP

Squarepoint’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Squarepoint’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-65,400
Closed -$301K – 1541
2016
Q1 		$301K Buy
65,400
+20,300
+45% +$81.6K 0.02% 824
2015
Q4 		$234K Buy
45,100
+32,700
+264% +$190K 0.03% 912
2015
Q3 		$75K Buy
+12,400
New +$152K 0.02% 380

Other funds holding RPTP

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Squarepoint's RPTP Position: Q2 2016 in Review

Squarepoint sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2016, closing a stake of 65,400 shares — an estimated $301K sold.

Squarepoint first reported a position in RPTP in Q3 2015 and held it in 3 quarters. The position peaked at $301K in Q1 2016. 93 funds tracked by Wall St. Rank hold RPTP as of Q2 2016.

  • Squarepoint reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Squarepoint sold 65,400 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2016, an estimated $301K.
  • Squarepoint first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2015 and held it in 3 quarters.
  • Squarepoint's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $301K in Q1 2016.
  • 93 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2016.

Based on Squarepoint's 13F filing for Q2 2016, filed 15 Aug 2016.